Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.65 |
| ▸ | FASN | P49327 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 2/20 | 0.55 |
| ▸ | CNR2 | P34972 | 2/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10977120 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL15440591 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL3227940 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL8403803 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL10980307 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL18185437 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL7121862 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL22749030 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL20499878 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR | |
| SCHEMBL14858316 | 1.00 | PTPN1 (0.65) | PTPN1FASNKDM4EALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117789993-A | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-03-29 | — | — | CN | claimed |
| CN-113490753-A | Endometrium liquid for predicting success of fertility treatment | 生育实验室科学有限责任公司 | 2021-10-08 | — | — | CN | claimed |
| CN-117500851-A | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 三菱瓦斯化学株式会社 | 2024-02-02 | — | — | CN | disclosed |
| CN-117500850-A | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 三菱瓦斯化学株式会社 | 2024-02-02 | — | — | CN | disclosed |
| CN-113490753-A | Endometrium liquid for predicting success of fertility treatment | 生育实验室科学有限责任公司 | 2021-10-08 | — | — | CN | disclosed |
| US-8680143-B2 | Orally active curcuminoid compounds | LAILA PHARMACEUTICALS PVT. LTD. (US) | 2014-03-25 | — | — | US | disclosed |
| EP-1702515-B1 | Fat or oil composition | KAO CORP (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20110112190-A1 | ORALLY ACTIVE CURCUMINOID COMPOUNDS | LAILA PHARMACEUTICALS PVT. LTD. (IN) | 2011-05-12 | — | — | US | disclosed |
| US-20110082193-A1 | TAXANE DERIVATIVE CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED THERAPEUTIC EFFICACY | KYSILKA VLADIMIR | 2011-04-07 | — | — | US | disclosed |
| EP-2294049-A2 | ORALLY ACTIVE CURCUMINOID COMPOUNDS | Laila Pharmaceuticals Pvt. Ltd. (IN) | 2011-03-16 | — | — | EP | disclosed |
| CN-1679403-B | Fat or oil processing food | KAO CORP | 2010-04-28 | — | — | CN | disclosed |
| EP-1702515-A2 | Fat or oil composition | Kao Corporation (JP) | 2006-09-20 | — | — | EP | disclosed |
| CN-1679403-A | Fat or oil composition | KAO CORP (JP) | 2005-10-12 | — | — | CN | disclosed |
| CN-1204819-C | Fat or oil composition | KAO CORP (JP) | 2005-06-08 | — | — | CN | disclosed |
| US-20030096867-A1 | To increase the HDL (High density lipoproteins) cholesterol level in blood for prophylaxis of arteriosclerosis | KAO CORPORATION (JP) | 2003-05-22 | — | — | US | disclosed |
| US-6495536-B1 | HIGH CONTENT OF DIACYLGLYCEROL; PHYTOSTEROL ADDED; EDIBLE OIL; REDUCING ARTERIOSCLEROTIC FACTORS IN BLOOD; PREVENTION OF ARTERIOSCLEROSIS AND VARIOUS DEGENERATIVE DISEASES | KAO CORPORATION (JP) | 2002-12-17 | — | — | US | disclosed |
| CN-1370050-A | Fat or oil composition | KAO CORP (JP) | 2002-09-18 | — | — | CN | disclosed |
| EP-0437520-B1 | TRIGLYCERIDE AND NUTRITIONAL COMPOSITION COMPRISING SUCH TRIGLYCERIDE | NOVO NORDISK A/S (DK) | 1992-04-15 | — | — | EP | disclosed |
| EP-0437520-A1 | TRIGLYCERIDE AND NUTRITIONAL COMPOSITION COMPRISING SUCH TRIGLYCERIDE. | NOVO NORDISK AS (DK) | 1991-07-24 | — | — | EP | disclosed |
| WO-1990004010-A1 | TRIGLYCERIDE, NUTRITIONAL COMPOSITION COMPRISING SUCH TRIGLYCERIDE, AND USE OF THE NUTRITIONAL COMPOSITION FOR NUTRITION | NOVO NORDISK A/S (DK) | 1990-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112190-A1 | ORALLY ACTIVE CURCUMINOID COMPOUNDS | ALOX12, ALOX15, ALOX15B | PTPN1 4616/4885FASN 65/4885KDM4E 2523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.